Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.10 | 5.48 |
PEG Ratio (TTM) | 0.00 | 1.49 |
P/S Ratio (TTM) | 1.29 | 2.44 |
P/B Ratio (TTM) | 0.10 | 2.42 |
P/FCF Ratio (TTM) | -2.55 | 87.34 |
Price to 5YR AVG Earnings Ratio | 0.00 | 125.93 |
Price to 5YR AVG FCF Ratio | -1.30 | -16.46 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -46.55% | 0.74% |
ROE (TTM) | -77.85% | -2.56% |
Net Profit Margin (TTM) | -504.99% | 2.34% |
ROIC 5YR AVG | -34.57% | -10.96% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -38.02% | -228.60% | -171.74% |
Revenue | 367.91% | 371.30% | 203.88% |
Net Income | -58.07% | -295.13% | -275.13% |
Cash Flow | -157.61% | -120.81% | -164.53% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.70 | 1.33 |
Quick Ratio (TTM) | 0.70 | 1.22 |
D/E Ratio (TTM) | 0.23 | -2.33 |
Interest Coverage (TTM) | 0.00 | -30.26 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | N/A | 2.15 |
LTL to 5YR AVG FCF | N/A | 23.71 |
Shares Outstanding Growth 5YR AVG | 46.01% | 4.35% |